Susquehanna International Group
FOLD

Susquehanna International Group’s Amicus Therapeutics FOLD Stock Holding History

Susquehanna International Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.16M Buy
149,341
+4,578
+3% +$65.6K ﹤0.01% 5998
2025
Q4 		$2.06M Buy
144,763
+123,180
+571% +$1.21M ﹤0.01% 5597
2025
Q3 		$170K Sell
21,583
-358,948
-94% -$2.55M ﹤0.01% 11152
2025
Q2 		$2.18M Sell
380,531
-156,176
-29% -$1.01M ﹤0.01% 5613
2025
Q1 		$4.38M Buy
536,707
+113,544
+27% +$1.05M ﹤0.01% 3905
2024
Q4 		$3.99M Buy
423,163
+201,076
+91% +$2.09M ﹤0.01% 3954
2024
Q3 		$2.37M Sell
222,087
-81,361
-27% -$886K ﹤0.01% 4953
2024
Q2 		$3.01M Buy
303,448
+201,825
+199% +$2.07M ﹤0.01% 4298
2024
Q1 		$1.2M Sell
101,623
-61,353
-38% -$785K ﹤0.01% 6458
2023
Q4 		$2.31M Sell
162,976
-97,792
-38% -$1.11M ﹤0.01% 5067
2023
Q3 		$3.17M Sell
260,768
-104,043
-29% -$1.34M ﹤0.01% 4279
2023
Q2 		$4.58M Buy
364,811
+48,340
+15% +$574K ﹤0.01% 3685
2023
Q1 		$3.51M Buy
316,471
+198,883
+169% +$2.45M ﹤0.01% 4005
2022
Q4 		$1.44M Sell
117,588
-195,062
-62% -$2.2M ﹤0.01% 5382
2022
Q3 		$3.26M Buy
312,650
+254,274
+436% +$2.83M ﹤0.01% 3909
2022
Q2 		$627K Sell
58,376
-117,585
-67% -$968K ﹤0.01% 7706
2022
Q1 		$1.67M Sell
175,961
-46,272
-21% -$434K ﹤0.01% 5885
2021
Q4 		$2.57M Sell
222,233
-92,236
-29% -$1.03M ﹤0.01% 4946
2021
Q3 		$3M Buy
314,469
+94,187
+43% +$963K ﹤0.01% 4950
2021
Q2 		$2.12M Sell
220,282
-108,077
-33% -$1.05M ﹤0.01% 5779
2021
Q1 		$3.24M Buy
328,359
+274,090
+505% +$4.24M ﹤0.01% 4786
2020
Q4 		$1.25M Sell
54,269
-109,932
-67% -$2.25M ﹤0.01% 6167
2020
Q3 		$2.32M Sell
164,201
-66,982
-29% -$976K ﹤0.01% 4336
2020
Q2 		$3.49M Buy
231,183
+26,106
+13% +$318K ﹤0.01% 3548
2020
Q1 		$1.9M Buy
205,077
+117,152
+133% +$1.11M ﹤0.01% 4069
2019
Q4 		$856K Sell
87,925
-208,087
-70% -$1.9M ﹤0.01% 5830
2019
Q3 		$2.37M Sell
296,012
-83,717
-22% -$909K ﹤0.01% 3873
2019
Q2 		$4.74M Buy
+379,729
New +$4.82M ﹤0.01% 2785
2019
Q1 		– Sell
-59,788
Closed -$730K – 9160
2018
Q4 		$573K Buy
59,788
+18,165
+44% +$200K ﹤0.01% 5771
2018
Q3 		$503K Sell
41,623
-577,114
-93% -$8.07M ﹤0.01% 6515
2018
Q2 		$9.66M Sell
618,737
-503,287
-45% -$7.61M ﹤0.01% 1963
2018
Q1 		$16.9M Buy
1,122,024
+171,711
+18% +$2.61M 0.01% 1342
2017
Q4 		$13.7M Buy
950,313
+217,985
+30% +$2.99M ﹤0.01% 1558
2017
Q3 		$11M Buy
732,328
+419,037
+134% +$5.54M ﹤0.01% 1683
2017
Q2 		$3.15M Buy
+313,291
New +$2.52M ﹤0.01% 3072
2017
Q1 		– Sell
-40,473
Closed -$256K – 9238
2016
Q4 		$201K Buy
+40,473
New +$280K ﹤0.01% 8643
2016
Q2 		– Sell
-16,852
Closed -$118K – 8765
2016
Q1 		$142K Sell
16,852
-103,568
-86% -$734K ﹤0.01% 8245
2015
Q4 		$1.17M Buy
120,420
+44,387
+58% +$400K ﹤0.01% 5107
2015
Q3 		$1.06M Sell
76,033
-33,053
-30% -$518K ﹤0.01% 5617
2015
Q2 		$1.54M Sell
109,086
-357,166
-77% -$4.29M ﹤0.01% 5259
2015
Q1 		$5.07M Buy
466,252
+315,311
+209% +$2.78M ﹤0.01% 2724
2014
Q4 		$1.26M Buy
150,941
+119,604
+382% +$821K ﹤0.01% 5410
2014
Q3 		$186K Sell
31,337
-213,008
-87% -$1.12M ﹤0.01% 8744
2014
Q2 		$816K Buy
244,345
+23,109
+10% +$54.2K ﹤0.01% 6473
2014
Q1 		$458K Sell
221,236
-56,427
-20% -$141K ﹤0.01% 6877
2013
Q4 		$653K Buy
277,663
+27,298
+11% +$59.9K ﹤0.01% 6269
2013
Q3 		$581K Buy
+250,365
New +$628K ﹤0.01% 6191

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna International Group's FOLD Position: Q1 2026 in Review

Susquehanna International Group increased its Amicus Therapeutics (FOLD) stake by 3.2% in Q1 2026, buying an estimated $65.6K and bringing the position to 149,341 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #5998.

Susquehanna International Group first reported a position in FOLD in Q3 2013 and has held it in 47 quarters since. The position peaked at $16.9M in Q1 2018. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Susquehanna International Group held 149,341 shares of Amicus Therapeutics worth $2.16M as of Q1 2026.
  • Susquehanna International Group bought 4,578 Amicus Therapeutics shares in Q1 2026, an estimated $65.6K.
  • Amicus Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5998 holding.
  • Susquehanna International Group first reported a position in Amicus Therapeutics in Q3 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Amicus Therapeutics position peaked at $16.9M in Q1 2018.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.